Piper logo

Piper Review

Best for: mainstream telehealth GLP-1 access

Telehealth weight loss provider offering competitively priced compounded GLP-1 medications.

By Eli Marsden · Founding Editor
Editorially reviewed (not clinically reviewed) · How we verify contentLast reviewed
7.6
★★★3.8
CompoundedSemaglutideTirzepatide
$135/mo
Same price at every dose

What the monthly price covers

Medication

Included

Provider visits

Included

Shipping

Included

Lab work

Not disclosed

Coaching

Not disclosed

See plans →

No insurance neededVetted by our editors

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

The Bottom Line

Piper is a solid telehealth option with balanced features and pricing.

Score: 7.6/10Best for: mainstream telehealth GLP-1 accessFrom: $135/mo
Piper logo
3.8 / 5
Our editorial rating
Visit Piper

from $135/mo · no insurance needed

Piper at a glance

Type
GLP-1 telehealth provider
Medications
Semaglutide, Tirzepatide
Starting price
$135/mo
Pricing model
Flat — dose increases don't raise the monthly price
What's included
Medication · Consult · Shipping
Availability
All 50 states
FDA status
No FDA warning letter on record

How we scored Piper

Each dimension is scored algorithmically from Piper’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.

Value25%

8.2/10

At $135/mo, Piper runs about 20% below the $170 median for GLP-1 providers. Pricing is flat across doses, so there is no escalation markup as you titrate up.

Effectiveness25%

7.9/10

Piper offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.

User Experience15%

6.8/10

Online intake and platform experience — consult included in the price; 3 platform features disclosed.

Trust & Safety15%

7.9/10

Key details fully confirmed by our editors; no FDA warning letters on file (last checked 2026-06-03).

Accessibility10%

8.0/10

Piper treats patients in all 50 states.

Support10%

5.6/10

Piper provides standard clinician follow-up; no extended coaching or community program is disclosed.

How we verified this Piper review

Last checked 2026-06-03
  • Confirmed current pricing across 2 dose/plan tiers
  • Confirmed availability in all 50 states
  • Confirmed what the monthly price does and doesn't include
  • Checked the FDA warning-letter database for enforcement actions
  • Walked the public intake/checkout flow on the provider's site

Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: high.

GLP-1 medications Piper offers

Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.

Pricing

StartingCompounded
$135/mo
semaglutide
StartingCompounded
$199/mo
tirzepatide

Ready to get started?

Plans and promotions change often — check Piper's current pricing and active discounts before you decide.

See Piper pricing →

What we like

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Watch-outs

  • Limited public information on program details

Piper: a low flat rate for compounded GLP-1s, with a name change to watch

Piper is a no-frills telehealth program built around one idea: charge the same low price for your compounded GLP-1 every month, no matter what dose you climb to. Compounded semaglutide starts at $135 a month and compounded tirzepatide runs a bit under two hundred dollars a month, and that figure is meant to be the whole bill, not a teaser. If you want cheap, predictable access to compounded medication and you don't need a lot of hand-holding or brand-name options, Piper is worth a look. The catch is that it publishes very little about how the program actually runs day to day, and it is in the middle of rebranding to Polly, so the name on your account and your shipping box may not match the one you signed up under.

How the flat pricing really works

Most compounding telehealth programs quietly raise your monthly cost as your dose increases, so the price you see at signup is rarely the price you pay six months in. Piper's model is the opposite: it advertises the same price for every dose, with no membership tier layered on top and no separate consult charge. The medication, the clinician visit, and shipping are all folded into that single monthly number. For semaglutide that means $135 a month from your first low dose through your maintenance dose; tirzepatide sits a little higher but follows the same flat structure.

For comparison, the category median for this kind of program lands around $170 a month, so Piper's semaglutide rate is meaningfully below the middle of the pack. That makes it one of the more aggressively priced options we track. Just remember this is self-pay only — Piper does not bill insurance — though it does say you can submit for HSA or FSA reimbursement, which softens the out-of-pocket sting for some people.

  • Same price at every dose — no step-ups as you titrate
  • No membership fee and no separate consultation charge
  • Free next-day air shipping included in the monthly price
  • Self-pay only, with HSA/FSA reimbursement available

What you get and how it ships

Piper offers compounded versions of both major GLP-1 molecules: semaglutide (the active ingredient in Ozempic and Wegovy) and tirzepatide (the active ingredient in Mounjaro and Zepbound). These are compounded formulations from a pharmacy, not the branded pens — so if having a brand-name product specifically matters to you, this isn't the provider for that. One genuinely nice operational detail is shipping: Piper advertises free next-day air, which is faster than the standard ground shipping most budget programs use, and it says the program is available in all 50 states through clinicians licensed where you live.

The rebrand you should know about

The most important thing to flag isn't pricing — it's identity. Piper is rebranding to Polly. The corporate entity behind it, Piper Wellness LLC, is now doing business as JoinPolly, and the website itself states that 'Piper is now Polly.' Practically, that means emails, your patient portal, payment descriptors, and packaging may show 'Polly' rather than 'Piper.' That isn't a red flag on its own — companies rename all the time — but if you're the type to worry about an unfamiliar charge or an unexpected sender, know in advance that the two names refer to the same operation.

Where Piper falls short

Our biggest reservation is transparency. Piper publishes the price and the basics, but it shares little detail about the specifics that careful patients care about: which compounding pharmacy fills the prescription, how clinical oversight and dose adjustments are handled, what the refund or cancellation terms are, and how side effects are managed between visits. We could not verify a named, accredited compounding partner for Piper, and the company doesn't spell out its medical-supervision model the way more established programs do. None of that is evidence of a problem, but it does mean you're trusting a lean, thinly documented program. There are no FDA warning letters on file against it, which is reassuring as far as it goes.

Who it's for — and who should skip it

Choose Piper (or Polly) if your priority is the lowest reasonable monthly price for compounded semaglutide or tirzepatide, you're comfortable with a self-pay, compounded-only model, and you don't need extensive coaching, lab work, or brand-name medication baked in. Skip it if you want brand-name pens, insurance billing, a clearly documented pharmacy and clinical team, or a high-touch program with nutrition and coaching support — other providers spell those things out far more clearly. You can see how we weigh price, transparency, and oversight in our scoring methodology.

Bottom line

Piper is a budget-first compounded GLP-1 program with a genuinely attractive hook: a flat monthly price that doesn't climb as your dose does, plus fast included shipping in all 50 states. For cost-conscious patients who know they want a compounded medication and don't need extras, that's a strong, simple value. Just go in clear-eyed about the two trade-offs — the limited public information on how the program is run, and the active rebrand to Polly — and confirm the current price and terms directly before you enroll.

If you're weighing alternatives, Oak ($130/month) and bmiMD ($99/month) are among the closest options we track to Piper.

Ready to start with Piper?

Starting at $135/month. See current pricing and start your free consultation.

Alternatives to Piper

8.6/ 10
Verified partner

Enhance MD

Best for: lab-monitored compounded GLP-1 with mandatory video visit

★★★★4.3

Editorial score · methodology

$49/mo
CompoundedSemaglutideTirzepatide
Get StartedRead full Enhance MD review →
8.5/ 10
Verified partner

Embody

Best for: lowest first-month entry pricing on compounded GLP-1s

★★★★4.3

Editorial score · methodology

$99/mo
CompoundedSemaglutideTirzepatide
Get StartedRead full Embody review →
8.5/ 10
Verified partner

TrimRx

Best for: best overall value

★★★★4.3

Editorial score · methodology

$179/mo
CompoundedSemaglutide
Get StartedRead full TrimRx review →

Frequently Asked Questions

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Sources

The primary regulatory filings and peer-reviewed studies cited throughout this Piper review:

Sources & methodology — as of July 2026
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)WeightLossRankings.org.
  2. 2.FDA — Compounding and the 503A Pharmacy FrameworkU.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)U.S. Food & Drug Administration.
  4. 4.PCAB — Pharmacy Compounding Accreditation Board StandardsAccreditation Commission for Health Care (ACHC) / PCAB.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)Kaiser Family Foundation.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)New England Journal of Medicine.PMID: 33567185.
  7. 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDAU.S. Food & Drug Administration.
  8. 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDAU.S. Food & Drug Administration.
  9. 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)New England Journal of Medicine.PMID: 35658024.
  10. 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDAU.S. Food & Drug Administration.
  11. 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDAU.S. Food & Drug Administration.
  12. 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)New England Journal of Medicine.PMID: 40334173.

Ready to start with Piper?

Starting at $135/month. See current pricing and start your free consultation.